NCT07781267
- Conditions
- 21-hydroxylase Deficiency, Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, +18 more
- Locations
-
- CHU de Lille Lille, France
Clinical trial condition
21-hydroxylase Deficiency
Explore clinical trials studying 21-hydroxylase Deficiency. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
21-hydroxylase Deficiency trial results
NCT00519818
- Conditions
- 21-hydroxylase Deficiency, Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, +18 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00542841
- Conditions
- 21-hydroxylase Deficiency, Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, +17 more
- Locations
-
- Mount Sinai School of Medicine New York, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- University of Sao Paolo São Paulo, Brazil
Completed
A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
NCT01495910
- Conditions
- 21-hydroxylase Deficiency, Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
- Locations
-
- Chicago, Illinois, United States
- Ann Arbor, Michigan, United States
- Dallas, Texas, United States
Related conditions
- Congenital adrenal hyperplasia due to 21 hydroxylase deficiency (4)
- Adrenal Gland Diseases (3)
- Adrenal Hyperplasia, Congenital (3)
- Congenital Abnormalities (3)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)
- Disorders of Sex Development (3)
- Endocrine System Diseases (3)
- Female Urogenital Diseases (3)